Evidence map›Paper›PMID 19036880›Full record

ArticleEndocrinology2009

Hexosamine biosynthesis pathway flux contributes to insulin resistance via altering membrane phosphatidylinositol 4,5-bisphosphate and cortical filamentous actin.

Padma Bhonagiri, Guruprasad R Pattar, Emily M Horvath, Kirk M Habegger, Alicia M McCarthy, Jeffrey S Elmendorf

RetractedOpen access · greenAbstract readRetracted Publication
In one paragraph

Article in Endocrinology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Padma BhonagiriDepartment of Cellular and Integrative Physiology, Indiana University School of Medicine, VanNuys Medical Science Building Room 308A, Indianapolis, Indiana 46202. jelmendo@iupui.edu.
Guruprasad R Pattar
Emily M Horvath
Kirk M Habegger
Alicia M McCarthy
Jeffrey S Elmendorf
Indiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

CHROMIUM ENHANCES INSULIN &GLUT4 ACTION VIA LIPID RAFTSR01AT001846 · NCCIH · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI ELMENDORF, JEFFREY S · 2004 to 2008
$1.4M
NUTRIENT STATE- & CHOLESTEROL-DEPENDENT ACTION OF CHROMIUMF31AT003977 · NCCIH · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI HORVATH, EMILY M. · 2006 to 2008
$105k
NCCIH NIH HHS F31 AT003977NCCIH NIH HHS F31-AT003977-01NCCIH NIH HHS R01 AT001846
6 · The paper itself

Abstract

We recently found that plasma membrane phosphatidylinositol 4,5-bisphosphate (PIP(2))-regulated filamentous actin (F-actin) polymerization was diminished in hyperinsulinemic cell culture models of insulin resistance. Here we delineated whether increased glucose flux through the hexosamine biosynthesis pathway (HBP) causes the PIP(2)/F-actin dysregulation and insulin resistance induced by hyperinsulinemia. Increased HBP activity was detected in 3T3-L1 adipocytes cultured under conditions closely resembling physiological hyperinsulinemia (5 nm insulin for 12 h) and in cells where HBP activity was amplified by 2 mm glucosamine (GlcN). Both the physiological hyperinsulinemia and experimental GlcN challenge induced comparable losses of PIP(2) and F-actin. In addition to protecting against the insulin-induced membrane/cytoskeletal abnormality and insulin-resistant state, exogenous PIP(2) corrected the GlcN-induced insult on these parameters. Moreover, in accordance with HBP flux directly weakening PIP(2)/F-actin structure, inhibition of the rate-limiting HBP enzyme (glutamine:fructose-6-phosphate amidotransferase) restored PIP(2)-regulated F-actin structure and insulin responsiveness. Conversely, overexpression of glutamine:fructose-6-phosphate amidotransferase was associated with a loss of detectable plasma membrane PIP(2) and insulin sensitivity. A slight decrease in intracellular ATP resulted from amplifying HBP by hyperinsulinemia and GlcN. However, experimental maintenance of the intracellular ATP pool under both conditions with inosine did not reverse the PIP(2)/F-actin-based insulin-resistant state. Furthermore, less invasive challenges with glucose, in the absence of insulin, also led to PIP(2)/F-actin dysregulation. Accordingly, we suggest that the functionality of cell systems dependent on PIP(2) and/or F-actin status, such as the glucose transport system, can be critically compromised by inappropriate HBP activity.

Indexed as

3T3-L1 CellsAcetylglucosamineActinsAdenosine TriphosphateAnimalsCell LineCell MembraneCytoskeletonFluorescent Antibody TechniqueGlycosylationHexosaminesInsulinInsulin ResistanceMicePhosphatidylinositol 4,5-DiphosphateSignal TransductionAcetylglucosamineActinsAdenosine TriphosphateHexosaminesInsulinPhosphatidylinositol 4,5-Diphosphate

Identifiers

PMID19036880
PMCPMC2659275
OpenAlexW2066663516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.